Preliminary poll results: big pharma alternative (BPA)


"The response to this initiative has been very poor; only 57 votes in 2 weeks. Quite depressing really!!"

"I am really not sure if the repurposing of off-patent drugs for MS is such a good idea after all. May be we should just maintain the status quo and let Big Pharma do what it does best; develop patented drugs under the current regulatory framework? This also raises ethical questions about whether or not we should be wasting precious resources on investigating off-patent drugs in MS if we don't have the mechanism to get them through a phase 3 program and then licensed. The latter is essential for adoption."

"I will leave the poll open to see if we can garner any further support!"



Previous post on the BPAMultiple Sclerosis Research: The BigPharma Alternative

29 Nov 2012; 
With the current level of risk associated with drug development and the level of regulatory red-tape it seems unlikely. Even Big Pharma themselves are having second thoughts about the current paradigm and trying new things ...

Labels: , , ,